Literature DB >> 34906417

KDIGO recommendations for the evaluation of glycemic control in advanced chronic kidney disease.

Vivian Fonseca1, Takuji Kohzuma2, Rodolfo J Galindo3, Cyrus DeSouza4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34906417      PMCID： PMC9354805          DOI： 10.1016/j.kint.2021.11.020

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   18.998


× No keyword cloud information.
  4 in total

1.  Influence of proteinuria on glycated albumin values in diabetic patients with chronic kidney disease.

Authors:  Tomonari Okada; Toshiyuki Nakao; Hiroshi Matsumoto; Yume Nagaoka; Ryo Tomaru; Hideaki Iwasawa; Toshikazu Wada
Journal:  Intern Med       Date:  2011-01-01       Impact factor: 1.271

2.  Serum glycated albumin predicts all-cause mortality in dialysis patients with diabetes mellitus: meta-analysis and systematic review of a predictive biomarker.

Authors:  Sidar Copur; Dimitrie Siriopol; Baris Afsar; Melis C Comert; Gizem Uzunkopru; Alan A Sag; Alberto Ortiz; Adrian Covic; Daniel H van Raalte; David Z Cherney; Peter Rossing; Mehmet Kanbay
Journal:  Acta Diabetol       Date:  2020-08-30       Impact factor: 4.280

3.  KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.

Authors: 
Journal:  Kidney Int       Date:  2020-10       Impact factor: 10.612

Review 4.  Glycated Albumin Versus HbA1c in the Evaluation of Glycemic Control in Patients With Diabetes and CKD.

Authors:  Ting Gan; Xin Liu; Gaosi Xu
Journal:  Kidney Int Rep       Date:  2017-11-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.